Morning All One thing keeps hanging in the back of my mine. Does anyone have the mandate of the SSR Team mandate and scope? I know we had a presentation but we should consider this as a part of our Review team scoping exercise. Any thoughts? Kind Regards Kerry-Ann Barrett Cyber Security Policy Specialist Organization of American States From: Gannon, James-1<mailto:james-1.gannon@novartis.com> Sent: Tuesday, April 18, 2017 7:33 AM To: Emily Taylor<mailto:emily.taylor@oxil.co.uk>; Jennifer Bryce<mailto:jennifer.bryce@icann.org> Cc: SSR2-review@icann.org<mailto:SSR2-review@icann.org> Subject: [EXT] Re: [Ssr2-review] Terms of Reference v2 Thanks Emily, And for the record as I didn’t put it in writing I’m happy to accept Denise’s suggested wording for the DNS Abuse topic. “Attacks and misuse of Identifier Systems, including the DNS. Has ICANN effectively fulfilled its limited role in threat mitigation and strengthening those systems capabilities” James Gannon IGM Manager – Projects & IT Security SME From: ssr2-review-bounces@icann.org [mailto:ssr2-review-bounces@icann.org] On Behalf Of Emily Taylor Sent: 18 April 2017 12:28 To: Jennifer Bryce <jennifer.bryce@icann.org> Cc: SSR2-review@icann.org Subject: Re: [Ssr2-review] Terms of Reference v2 Dear Jennifer and SSR2 team members Thank you for preparing the updated draft of the Terms of Reference. I have made a few comments and suggested edits, in my capacity as a member of the team, rather than a co-chair. I look forward to continuing our discussions. Best Emily On Sat, Apr 15, 2017 at 2:39 PM, Cathy Handley <chandley@arin.net<mailto:chandley@arin.net>> wrote: thanks Jennifer! Cathy Cathy Handley Executive Director Government Affairs American Registry for Internet Numbers (ARIN) Mobile: +1 703 341 7996<tel:(703)%20341-7996> Fax: +1 703 263 0111<tel:(703)%20263-0111> Email: chandley@arin.net<mailto:chandley@arin.net> Confidentiality Notice: This message is intended only for the use of the individual or entity to which it is addressed, and may contain information that is privileged, confidential, and exempt from disclosure under applicable law. If the reader of this message is not the intended recipient, you are hereby notified that any dissemination, distribution, or copying of this communication is strictly prohibited. If you have received this communication in error, please delete.. Thank you. On Apr 14, 2017, at 3:47 AM, Jennifer Bryce <jennifer.bryce@icann.org<mailto:jennifer.bryce@icann.org>> wrote: Dear all, Please find attached a revised Terms of Reference document for the Review Team’s discussion and input. Per the request of the Review Team, redline changes from team members have been accepted in this version 2, unless there was disagreement or objection. Comments that require further discussion have been left in. Comments in this document focus on: • Definitions of key terms • Scope, including: o DNS abuse o gTLD, ccTLD abuse o Actual/potential future challenges and threats o Forecasting research on Internet capacity/performance • Timeline • Responsibilities of team members • Inclusion of specific groups to outreach to Best, Jennifer -- Jennifer Bryce Senior Reviews Coordinator Internet Corporation for Assigned Names and Numbers (ICANN) Email: jennifer.bryce@icann.org<mailto:jennifer.bryce@icann.org> Skype: jennifer.bryce.icann www.icann.org<http://www.icann.org/> <SSR2-TermsofReference-v2.0JB.docx>_______________________________________________ Ssr2-review mailing list Ssr2-review@icann.org<mailto:Ssr2-review@icann.org> https://mm.icann.org/mailman/listinfo/ssr2-review _______________________________________________ Ssr2-review mailing list Ssr2-review@icann.org<mailto:Ssr2-review@icann.org> https://mm.icann.org/mailman/listinfo/ssr2-review -- Emily Taylor CEO, Oxford Information Labs Associate Fellow, Chatham House; Editor, Journal of Cyber Policy PLEASE NOTE MY NEW EMAIL ADDRESS AND CONTACTS AS OF 1 JANUARY 2017 Magdalen Centre, Oxford OX4 4GA | T: 01865 582885 E: emily.taylor@oxil.co.uk<mailto:emily.taylor@oxil.co.uk> | D: 01865 582811 | M: +44 7540 049322 [https://s3-eu-west-1.amazonaws.com/static.oxil/oxil_logo-150x.png] [https://docs.google.com/a/oxil.co.uk/uc?id=0B7sS_6djDxsHNm92d21jM21HMDQ&expo...] <http://explore.tandfonline.com/cfp/pgas/rcyb-cfp-2017> Registered office: 37 Market Square, Witney, Oxfordshire OX28 6RE. Registered in England and Wales No. 4520925. VAT No. 799526263 . Novartis Ireland Ltd. Registered No. 11931, Ireland. Registered Office: The Vista Building, Elm Park Business Park, Merrion Road, Dublin 4. DO4 A9N6, Ireland. Confidentiality Notice: This e-mail message, including any attachments, is for the sole use of the intended recipient(s) and may contain confidential and privileged information. Any unauthorized review, use, disclosure or distribution is prohibited. If you are not the intended recipient, please contact the sender by reply e-mail and destroy all copies of the original message.